- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07795671
Rotational Stability of Two Soft Toric Contact Lens Designs
August 29, 2026 updated by: Koçer Furkan Durukan, Bozok University
Comparison of Rotational Behavior of Soft Toric Contact Lenses With Different Stabilization Designs and Their Association With Ocular Biometric Parameters
This study compared the rotational behavior of two commercially available soft toric contact lenses with different stabilization designs and explored whether ocular biometric and refractive characteristics were associated with lens rotation.
Contact lens-naïve adults underwent baseline ocular biometry and were scheduled for two separate lens-fitting sessions in randomized order.
Lens rotation was measured 30 minutes after insertion in primary, right, left, upward, and downward gaze using slit-lamp biomicroscopy.
The study was designed as a two-period crossover comparison.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Yozgat
-
Yozgat, Yozgat, Turkey (Türkiye), 66100
- Yozgat Bozok University Research and Application Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adults with astigmatic refractive error suitable for correction with the -commercially available toric contact lenses used in the study
- No prior experience with contact lens wear
- Healthy ocular surface examination
- Ability and willingness to provide written informed consent
Exclusion Criteria:
- History of corneal pathology
- Previous ocular surgery
- Active ocular disease
- Systemic disease affecting the eyes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: ASD First, Modified Periballast Second
Participants received the accelerated stabilization design lens at the first fitting session and the modified periballast lens at the second fitting session after a 4-day interval.
|
Commercially available soft toric contact lens composed of senofilcon A, with an 8.6-mm base curve and 14.5-mm diameter, using an accelerated stabilization design.
Commercially available soft toric contact lens composed of lotrafilcon B, with an 8.7-mm base curve and 14.5-mm diameter, using a modified periballast stabilization design.
|
|
Other: Modified Periballast First, ASD Second
Participants received the modified periballast lens at the first fitting session and the accelerated stabilization design lens at the second fitting session after a 4-day interval.
|
Commercially available soft toric contact lens composed of senofilcon A, with an 8.6-mm base curve and 14.5-mm diameter, using an accelerated stabilization design.
Commercially available soft toric contact lens composed of lotrafilcon B, with an 8.7-mm base curve and 14.5-mm diameter, using a modified periballast stabilization design.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Mean Absolute Contact Lens Rotation
Time Frame: 30 minutes after lens insertion during each fitting session
|
Absolute lens rotation was measured in degrees using slit-lamp biomicroscopy in five gaze positions (primary, right, left, upward, and downward gaze).
For each lens design, the overall mean absolute rotation was calculated as the average of the absolute rotation measurements across the five gaze positions.
|
30 minutes after lens insertion during each fitting session
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 2, 2026
Primary Completion (Actual)
July 1, 2026
Study Completion (Actual)
July 1, 2026
Study Registration Dates
First Submitted
August 26, 2026
First Submitted That Met QC Criteria
August 26, 2026
First Posted (Actual)
August 31, 2026
Study Record Updates
Last Update Posted (Actual)
September 1, 2026
Last Update Submitted That Met QC Criteria
August 29, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- TORIC-ROT-2026-01
- 2026-GOKAEK-267_2026.04.01_98 (Other Identifier: Yozgat Bozok University Clinical Research Ethics Committee)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
De-identified individual participant data underlying the results reported in the published article, including demographic, refractive, ocular biometric, and contact lens rotation measurements, may be shared upon reasonable request.
No directly identifying information will be provided.
IPD Sharing Time Frame
Data will be available beginning after publication of the primary study results and will remain available for 5 years following publication.
IPD Sharing Access Criteria
Data may be provided to qualified researchers who submit a methodologically sound scientific proposal to the corresponding author.
Requests will be evaluated for scientific purpose, participant confidentiality, applicable ethical and institutional requirements, and compatibility with the original informed consent.
A data use agreement may be required where appropriate.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.